1. Home
  2. BANR vs AKRO Comparison

BANR vs AKRO Comparison

Compare BANR & AKRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BANR
  • AKRO
  • Stock Information
  • Founded
  • BANR 1890
  • AKRO 2017
  • Country
  • BANR United States
  • AKRO United States
  • Employees
  • BANR N/A
  • AKRO N/A
  • Industry
  • BANR Major Banks
  • AKRO Biotechnology: Pharmaceutical Preparations
  • Sector
  • BANR Finance
  • AKRO Health Care
  • Exchange
  • BANR Nasdaq
  • AKRO Nasdaq
  • Market Cap
  • BANR 2.2B
  • AKRO 2.4B
  • IPO Year
  • BANR 1995
  • AKRO 2019
  • Fundamental
  • Price
  • BANR $74.50
  • AKRO $32.38
  • Analyst Decision
  • BANR Buy
  • AKRO Strong Buy
  • Analyst Count
  • BANR 6
  • AKRO 7
  • Target Price
  • BANR $61.20
  • AKRO $43.20
  • AVG Volume (30 Days)
  • BANR 256.0K
  • AKRO 554.0K
  • Earning Date
  • BANR 10-16-2024
  • AKRO 11-08-2024
  • Dividend Yield
  • BANR 2.56%
  • AKRO N/A
  • EPS Growth
  • BANR N/A
  • AKRO N/A
  • EPS
  • BANR 4.78
  • AKRO N/A
  • Revenue
  • BANR $593,391,000.00
  • AKRO N/A
  • Revenue This Year
  • BANR N/A
  • AKRO N/A
  • Revenue Next Year
  • BANR $4.01
  • AKRO N/A
  • P/E Ratio
  • BANR $15.65
  • AKRO N/A
  • Revenue Growth
  • BANR N/A
  • AKRO N/A
  • 52 Week Low
  • BANR $42.00
  • AKRO $13.86
  • 52 Week High
  • BANR $77.01
  • AKRO $37.00
  • Technical
  • Relative Strength Index (RSI)
  • BANR 68.62
  • AKRO 55.64
  • Support Level
  • BANR $67.14
  • AKRO $31.12
  • Resistance Level
  • BANR $77.01
  • AKRO $35.11
  • Average True Range (ATR)
  • BANR 2.34
  • AKRO 1.74
  • MACD
  • BANR 0.89
  • AKRO 0.11
  • Stochastic Oscillator
  • BANR 81.85
  • AKRO 53.31

About BANR Banner Corporation

Banner Corp is a bank holding company. It wholly owns one subsidiary bank, Banner Bank. The Bank's primary business is that of traditional banking institutions, accepting deposits and originating loans in locations surrounding its offices in Washington, Oregon, California, Idaho and Utah. Banner Bank also actively participates in the secondary loan markets, engaging in mortgage banking operations largely through the origination and sale of one to four family residential loans.

About AKRO Akero Therapeutics Inc.

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.

Share on Social Networks: